Reduction in Urinary CD163 Associated with Treatment Response in the Belimumab Lupus Nephritis Trial
1 tracks • 0 plays • 0 favorites
Reduction in Urinary CD163 Associated with Treatment Response in the Belimumab Lupus Nephritis Trial
user4304645171849
0:0014:35
News
Episodes
1
Reduction in Urinary CD163 Associated with Treatment Response in the Belimumab Lupus Nephritis Trial
user4304645171849